Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the modification of cystic fibrosis phenotypes by SLC9A3
FY 2014-15
Summary
Cystic Fibrosis (CF) is a common genetic disorder is caused by a mutation in the cystic fibrosis transmembrane regulator (CFTR) gene that leads to an obstructive buildup of thick and viscous fluid that covers organs, such as the lungs and digestive system. However, individuals with cystic fibrosis exhibit variable disease severity despite having common mutations in the CFTR gene. In addition to environmental factors, twin and sibling studies have revealed that other genes may also contribute to the variation. One such gene is SLC9A3 , which works with CFTR to maintain salt and water balance at the surface of organs. Small changes in the SLC9A3 gene have been associated with cystic fibrosis symptoms such as lung disease and infection and infantile intestinal obstruction. Interestingly, larger changes in the number of copies of the whole or portions of the SLC9A3 gene, which would have a greater impact on SLC9A3 function, have been found in healthy individuals and CF patients. However, how these changes in copy number of the SLC9A3 gene are involved in cystic fibrosis is unknown. This study will determine the number of copies of the SLC9A3 gene in 500 Canadian individuals with CF and see how these changes relate to cystic fibrosis. By understanding how SLC9A3 modifies cystic fibrosis, it will help develop new therapies that will complement current CFTR-focused therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331312
Name
Chan Ada
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the modification of cystic fibrosis phenotypes by SLC9A3
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Copy Number Variations; Cystic Fibrosis; Human Genetics; Modifier Genes; Slc9a3
Abstract
Cystic Fibrosis (CF) is a common genetic disorder is caused by a mutation in the cystic fibrosis transmembrane regulator (CFTR) gene that leads to an obstructive buildup of thick and viscous fluid that covers organs, such as the lungs and digestive system. However, individuals with cystic fibrosis exhibit variable disease severity despite having common mutations in the CFTR gene. In addition to environmental factors, twin and sibling studies have revealed that other genes may also contribute to the variation. One such gene is SLC9A3 , which works with CFTR to maintain salt and water balance at the surface of organs. Small changes in the SLC9A3 gene have been associated with cystic fibrosis symptoms such as lung disease and infection and infantile intestinal obstruction. Interestingly, larger changes in the number of copies of the whole or portions of the SLC9A3 gene, which would have a greater impact on SLC9A3 function, have been found in healthy individuals and CF patients. However, how these changes in copy number of the SLC9A3 gene are involved in cystic fibrosis is unknown. This study will determine the number of copies of the SLC9A3 gene in 500 Canadian individuals with CF and see how these changes relate to cystic fibrosis. By understanding how SLC9A3 modifies cystic fibrosis, it will help develop new therapies that will complement current CFTR-focused therapies.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chan, Ada
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~